+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Surfactant therapy in late preterm infants: respiratory distress syndrome and beyond



Surfactant therapy in late preterm infants: respiratory distress syndrome and beyond



Turkish Journal of Pediatrics 54(3): 239-246



A significant ratio of late preterm infants receives surfactant therapy (ST) for respiratory distress syndrome (RDS) and for other neonatal lung diseases characterized by surfactant inactivation or dysfunction. We aimed to investigate the clinical and therapeutic characteristics and outcomes of late preterm infants who received ST in the last 10 years in our neonatal intensive care unit. During the 10-year period, 77 late preterm infants received ST. The underlying lung diseases were RDS in 51 (66.2%), congenital pneumonia in 15 (19.5%), congenital diaphragmatic hernia in 4 (5.2%), pulmonary edema due to hydrops fetalis in 4 (5.2%), and acute respiratory distress syndrome (ARDS) in 3 (3.9%) infants. Pulmonary hypertension was a significant predictive factor for mortality. Although RDS was the main cause of respiratory failure in late preterm infants, other lung diseases leading to surfactant dysfunction were not rare; therefore, ST should be considered as a life-saving treatment.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 056026317

Download citation: RISBibTeXText

PMID: 23094533


Related references

Effects of surfactant treatment in late preterm infants with respiratory distress syndrome. Journal of Maternal-Fetal and Neonatal Medicine 31(10): 1259-1266, 2018

Effect of exogenous surfactant therapy on levels of pulmonary surfactant proteins A and D in preterm infants with respiratory distress syndrome. Journal of Perinatal Medicine 37(5): 561-564, 2009

Surfactant therapy in respiratory failure other than respiratory distress syndrome in term and preterm infants. Pediatric Research 31(4 Part 2): 323A, 1992

A multicenter study on the surfactant treatment in late-preterm or term infants with respiratory distress syndrome. Zhonghua Er Ke Za Zhi 52(10): 724-728, 2014

The effectiveness of surfactant replacement therapy for preterm infants with respiratory distress syndrome. Medical Journal of Malaysia 53(4): 376-384, 1998

Analysis of the cost-effectiveness of surfactant treatment (Curosurf®) in respiratory distress syndrome therapy in preterm infants: early treatment compared to late treatment. Italian Journal of Pediatrics 40: 40, 2014

Early use of calf pulmonary surfactant in late preterm and full-term infants with respiratory distress syndrome: a randomized controlled trial. Zhongguo Dang Dai Er Ke Za Zhi 16(3): 285-289, 2014

Comparison of outcome of preterm infants with respiratory distress syndrome receiving postnatal steroid therapy with and without surfactant. Pediatric Research 35(4 Part 2): 337A, 1994

Early prophylactic versus late selective use of surfactant for respiratory distress syndrome in very preterm infants: a collaborative study of 53 multi-center trials in Korea. Journal of Korean Medical Science 29(8): 1126-1131, 2014

Exogenous surfactant therapy in infants with respiratory distress syndrome comparison of early vs. late treatment. Pediatric Research 18(4 Part 2): 353A, 1984

Pulmonary mechanics in ventilated preterm infants with respiratory distress syndrome after exogenous surfactant administration: a comparison between two surfactant preparations. Pediatric Pulmonology 18(5): 273-278, 1994

Modified bovine surfactant versus a protein-free surfactant in the treatment of respiratory distress syndrome in preterm infants A pilot study. Journal of the National Medical Association 86(1): 46-52, 1994

Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis. Archives of Disease in Childhood. Fetal and Neonatal Edition 102(1): F17-F23, 2017

Synthetic surfactant for respiratory distress syndrome in preterm infants. Cochrane Database of Systematic Reviews 2000(2): Cd001149, 2000

Surfactant replacement in preterm infants with respiratory distress syndrome. Acta Bio-Medica 83(Suppl. 1): 17-20, 2012